Economic evaluation of meningococcal vaccines: considerations for the future
Date
2020Dewey
Economie socialeSujet
Cost-effectiveness; Meningitis; Meningococcal; QALY; VaccineJEL code
I.I1.I18Journal issue
The European Journal of Health EconomicsVolume
21Publication date
2020Article pages
297-309Publisher
SpringerCollections
Metadata
Show full item recordAuthor
Christensen, Hannah
545763 Bristol Renal, Bristol Medical School
Al-Janabi, Hareth
164366 Department of Economics
Lévy, Pierre
163517 Laboratoire d'Economie et de Gestion des Organisations de Santé [Legos]
559342 Laboratoire d'Economie de Dauphine [LEDa]
559342 Laboratoire d'Economie de Dauphine [LEDa]
Postma, Maarten J.
1021737 FACULTY OF ECONOMICS UNIVERSITY OF GRONINGEN PAYS- BAS NLD
Bloom, David E.
199325 Department of Society, Human Development, and Health, Harvard School of Public Health, Boston
Landa, Paolo
460277 University of Exeter Medical School
Salisbury, David M.
Diez-Domingo, Javier
554767 Unit of Public Health and Environmental Care, Department of Preventive Medicine, University of Valencia, Burjassot, Valencia, Spain
Towse, Adrian K.
Lorgelly, Paula K.
Shah, Koonal K.
Hernandez-Villafuerte, Karla
480809 Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Smith, Vinny
Glennie, Linda
Wright, Claire
York, Laura
Farkouh, Raymond
150695 Pfizer Inc